Epigral's Q2 FY 2025-26 Quarterly Results

Result Summary

• Epigral Ltd reported a 4.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 6.7%.
• Its expenses for the quarter were up by 2.2% QoQ and 2.4% YoY.
• The net profit decreased 68.1% QoQ and decreased 37.0% YoY.
• The earnings per share (EPS) of Epigral Ltd stood at 11.87 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Epigral Ltd is a company engaged in delivering various products and services within its industry. However, specific details about the company's main products or services, the industry it operates in, and any recent major developments are not available within the provided data. This report will focus on an analysis of the company's financial performance based solely on the provided quarterly financial data.

Revenue

In Q2FY26, Epigral Ltd reported a total income of ₹589.10 crores. This represents a decrease of 4.2% from the previous quarter, Q1FY26, where total income was ₹614.79 crores. Furthermore, when compared to the same quarter in the previous fiscal year, Q2FY25, where the total income was ₹631.61 crores, there is a year-over-year decline of 6.7%. These figures illustrate the changes in the company's revenue generation over the specified periods.

Profitability

The Profit Before Tax (PBT) for Q2FY26 was ₹69.95 crores, which signifies a significant decline of 34.5% from the previous quarter, Q1FY26, with a PBT of ₹106.73 crores. Compared to Q2FY25, where the PBT was ₹124.41 crores, there is a year-over-year drop of 43.8%. The Profit After Tax (PAT) for Q2FY26 was ₹51.22 crores, marking a 68.1% decrease compared to Q1FY26's PAT of ₹160.69 crores, and a 37.0% decrease compared to Q2FY25's PAT of ₹81.30 crores. The Earnings Per Share (EPS) also reflects these changes, with a value of ₹11.87 in Q2FY26, down from ₹37.25 in the prior quarter and ₹19.57 in the corresponding quarter last year.

Operating Metrics

The total expenses for Epigral Ltd in Q2FY26 were ₹519.15 crores, which is a 2.2% increase from Q1FY26's total expenses of ₹508.06 crores. Compared to Q2FY25, where the expenses were ₹507.20 crores, there is a year-over-year increase of 2.4%. The tax expense for Q2FY26 was ₹18.43 crores, which shows a dramatic change from the negative tax figure of -₹53.68 crores in Q1FY26. In comparison to Q2FY25, where the tax expense was ₹43.88 crores, there is a 58.0% reduction. These figures highlight the variations and trends in the company's operating costs and tax obligations over the specified periods.